CytomX Therapeutics (CTMX) Return on Sales [ROS] (2014 - 2026)
CytomX Therapeutics (CTMX) posted Return on Sales [ROS] of -1677.08% for Q2 2026, down 1670.19 percentage points from -6.89% a year earlier and down 1485.31 percentage points from the prior quarter.
CytomX Therapeutics (CTMX) Return on Sales [ROS] (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at CytomX Therapeutics was -476.19%, down 506.76 percentage points year-over-year; for FY2025, it came in at -29.35%, down 47.45 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +88.35 percentage points (FY2020 to FY2025).
- In prior years, CytomX Therapeutics' Return on Sales [ROS] was 18.10% in FY2024 (+24.51 pp), -6.41% in FY2023 (+184.21 pp), -190.61% in FY2022 (+120.39 pp) and -311.00% in FY2021 (-193.30 pp).
- Quarterly Return on Sales [ROS] has run from a low of -4212.97% in Q4 2025 to a high of 46.41% in Q4 2024 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last four quarters, with an average year-over-year change of -793.78 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2023, with a gain of 330.61 percentage points; the weakest was Q4 2025, with a drop of 4259.38 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -191.77% (Q1 2026), -4212.97% (Q4 2025) and -264.43% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | CytomX Therapeutics | 431.65 Mn | -730.37 Mn | - | -1,392.30% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,392.30% |
| Jun 30, 2026 | -1,677.08% |
| Mar 31, 2026 | -191.77% |
| Dec 31, 2025 | -4,212.97% |
| Sep 30, 2025 | -264.43% |
| Jun 30, 2025 | -6.89% |
| Mar 31, 2025 | 44.43% |
| Dec 31, 2024 | 46.41% |
| Sep 30, 2024 | 12.30% |
| Jun 30, 2024 | -33.65% |
| Mar 31, 2024 | 28.11% |
| Dec 31, 2023 | -2.28% |
| Sep 30, 2023 | 11.84% |
| Jun 30, 2023 | -13.54% |
| Mar 31, 2023 | -24.06% |
| Dec 31, 2022 | -47.25% |
| Sep 30, 2022 | -266.53% |
| Jun 30, 2022 | -233.83% |
| Mar 31, 2022 | -354.67% |
| Dec 31, 2021 | -313.54% |
CytomX Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();